Q3 2020 Seres Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Seres Therapeutics Third Quarter 2020 Earnings Conference Call. (Operator Instructions) Please be advised that this call is being recorded. (Operator Instructions)
I would now like to hand the conference over to Dr. Carlo Tanzi, Investor Relations. Thank you. Please go ahead, sir.
Thank you, and good morning. A press release with the company's third quarter 2020 financial results and the business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors and News section of the company's website.
I'd like to remind you that we'll be making forward-looking statements relating to the timing, enrollment and results of our clinical studies, regulatory approval, the promise and potential impact of any of our microbiome therapeutics and the sufficiency of our cash and cash equivalents to fund operations. Actual results may differ materially.
Additionally,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |